Company / Working Capital
ORAGENICS INC Working Capital History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$12.7M
FY2022
5-year range
$12.7M / $26.3M
FY2018-FY2022
Trend
-51.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $21M to $13M over the past 4 years.
Based on SEC 10-K filings.
$13M in FY2022 with a 5-year CAGR of +15.1%.
Declined from $21M to $13M over the past 4 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2022, working capital decreased 51.7% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $12.7M | -51.7% |
| FY2021 | $26.3M | +26.5% |
| FY2018 | $20.8M | +229.9% |
| FY2017 | $6.3M | +118.7% |
| FY2016 | $2.9M | -37.3% |
| FY2015 | $4.6M | -55.1% |
| FY2014 | $10.2M | -35.3% |
| FY2013 | $15.8M | +72.9% |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026